What should be the core outcomes in chronic pain clinical trials?

A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted.

[1]  D Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.

[2]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[3]  R A Deyo,et al.  Outcome Measures for Low Back Pain Research: A Proposal for Standardized Use , 1998, Spine.

[4]  Bryan R. Luce,et al.  Health care technology and its assessment : an international perspective , 1993 .

[5]  Richard Coles,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 1998. , 2002, Vital and health statistics. Series 10, Data from the National Health Survey.

[6]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[7]  Jeannine S. Schiller,et al.  Summary health statistics for U.S. adults: National Health Interview Survey, 2001. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.

[8]  N. Hollenberg,et al.  Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. , 1999, Archives of internal medicine.

[9]  P. Tugwell,et al.  Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. , 1997, The Journal of rheumatology.

[10]  M. Testa,et al.  Symptom Distress Checklists as a Component of Quality of Life Measurement: Comparing Prompted Reports by Patient and Physician with Concurrent Adverse Event Reports via the Physician , 1994 .

[11]  F. V. Abbott,et al.  Use and abuse of over-the-counter analgesic agents. , 1998, Journal of psychiatry & neuroscience : JPN.

[12]  D. Commerce.  Statistical abstract of the United States , 1978 .

[13]  Gordon Waddell,et al.  The Back Pain Revolution , 1998 .